Immuno-Biological Laboratories Co., Ltd. (TYO:4570)

TYO:4570 Revenue

In the fiscal year ending March 31, 2026, Immuno-Biological Laboratories had annual revenue of 1.00B JPY with 3.61% growth. Immuno-Biological Laboratories had revenue of 262.00M in the quarter ending March 31, 2026, a decrease of -9.34%.

• Revenue: 1.00B
• Revenue Growth: +3.61%
• P/S Ratio: 9.39
• Revenue / Employee: 17.31M
• Employees: 58
• Market Cap: 9.43B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.00B	35.00M	3.61%
Mar 31, 2025	969.00M	153.00M	18.75%
Mar 31, 2024	816.00M	22.00M	2.77%
Mar 31, 2023	794.00M	147.00M	22.72%
Mar 31, 2022	647.00M	45.00M	7.48%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error